Hence, HDAC1,2 inhibition appears to overcome chemoresistance mediated by both EZH2 and BBAP by affecting regulators of genome stability in the chemoresistant EZH2GOF DLBCL cells and by activating the transcription of DNA damage response genes independent of EZH2 function. The gene discussed is HDAC1; the disease is diffuse large B-cell lymphoma.